Barclays Downgrades Chimera Investment Corp (CIM) to Underweight; Risk/Reward Unfavorable as Dividend Concerns Remains

Article Stock Quotes (1) Comments (0)

Barclays downgraded Chimera Investment Corp (NYSE: CIM) from Equalweight to Underweight with a price target of $2.25 (from $2.50).

Analyst, Mark C. DeVries, said, "...we believe the stock could continue to underperform the group until it is able to provide updated disclosure (we still do not have financials for 4Q11 and 1Q12), and allay concerns about ongoing pressure on the dividend, which management recently lowered for the 5th time in the last 7 quarters, taking it down to half of the 3Q10 high."

For an analyst ratings summary and ratings history on Chimera Investment Corp click here. For more ratings news on Chimera Investment Corp click here.

Shares of Chimera Investment Corp closed at $2.62 yesterday, with a 52 week range of $2.38-$3.62.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
• Chimera Investment (CIM) Declares $0.09 Quarterly Dividend; Says Book Value $3.55/Share
• UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

Barclays, Dividend

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?